Barry Greene
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barry Greene
The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $10,348,318 for Barry Greene in fiscal 2020, including a base salary of $484,000. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Alnylam Pharmaceuticals, Inc. (ALNY)
Proxy statement
Start not stated–2021-04-02
Last confirmed by a filing; no departure on record
-
Alnylam Pharmaceuticals, Inc. (ALNY)
Proxy statement
Start not stated–2020-09-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former President | $484,000 | $10,348,318 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former President | $596,820 | $3,118,364 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | Former President | $580,000 | $2,994,383 |
| 2017 | Alnylam Pharmaceuticals, Inc. (ALNY) | President | $562,792 | $944,145 |
Recent activity
No call appearances or filed executive changes recorded yet.